|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||
| Current assets: | |||||||||||||||||||
| Cash | |||||||||||||||||||
| Accounts receivable ($0 and $1,567 from related parties, respectively) | |||||||||||||||||||
| Prepaid expenses and other current assets | |||||||||||||||||||
| Total current assets | |||||||||||||||||||
| Prepaid insurance, long-term | |||||||||||||||||||
| Marketable securities held in Trust Account | |||||||||||||||||||
| Property and equipment, net | |||||||||||||||||||
| Operating lease right-of-use assets | |||||||||||||||||||
| Deferred offering costs | |||||||||||||||||||
| Other non-current assets | |||||||||||||||||||
| Total assets | |||||||||||||||||||
| Current liabilities: | |||||||||||||||||||
| Accrued expenses | |||||||||||||||||||
| Accounts payable and accrued expenses | |||||||||||||||||||
| Accrued interest payable – related party | |||||||||||||||||||
| Accrued offering costs | |||||||||||||||||||
| Accounts payable | |||||||||||||||||||
| Accrued expenses and other current liabilities | |||||||||||||||||||
| Deferred legal fees | |||||||||||||||||||
| Other liabilities | |||||||||||||||||||
| Operating lease liability, current | |||||||||||||||||||
| Equity line of credit commitment payable | |||||||||||||||||||
| Forward purchase agreement settlement liability | |||||||||||||||||||
| Convertible promissory notes, current ($300 to related parties) | |||||||||||||||||||
| Senior secured notes, current | |||||||||||||||||||
| Note payable - related party, current | |||||||||||||||||||
| Total current liabilities | |||||||||||||||||||
| Convertible note - related party | |||||||||||||||||||
| Deferred legal fee | |||||||||||||||||||
| Deferred underwriting fee payable | |||||||||||||||||||
| Forward purchase agreement derivative liability | |||||||||||||||||||
| Senior secured notes | |||||||||||||||||||
| Non-current liabilities | |||||||||||||||||||
| Note payable - related party, non-current | |||||||||||||||||||
| Accrued expenses and other current liabilities | |||||||||||||||||||
| Other liabilities | |||||||||||||||||||
| Convertible promissory notes, current ($300 to related parties) | |||||||||||||||||||
| Senior secured notes, current | |||||||||||||||||||
| Total liabilities | |||||||||||||||||||
| Class A ordinary shares subject to possible redemption; $0.0001 par value; 7,894,801 and 23,000,000 shares issued and outstanding at redemption value of $10.93 and $10.40 per share as of December 31, 2023 and 2022, respectively | |||||||||||||||||||
| Total class A ordinary shares subject to possible redemption; $0.0001 par value; 7,894,801 and 23,000,000 shares issued and outstanding at redemption value of $10.93 and $10.40 per share as of December 31, 2023 and 2022, respectively | |||||||||||||||||||
| Stockholders’ equity (deficit) | |||||||||||||||||||
| Convertible preferred stock value | |||||||||||||||||||
| Convertible preferred stock, value | |||||||||||||||||||
| Series A Convertible Preferred Stock | |||||||||||||||||||
| Series C Convertible Preferred Stock | |||||||||||||||||||
| Series D Convertible Preferred Stock | |||||||||||||||||||
| Total convertible preferred stock, value | |||||||||||||||||||
| Common Stock, $0.0001 par value; 600,000,000 shares authorized; 194,321,718 and 172,318,506 shares issued and outstanding at September 30, 2026 and December 31, 2025, respectively | |||||||||||||||||||
| Common Class A | |||||||||||||||||||
| Common Class B | |||||||||||||||||||
| Total common Stock, $0.0001 par value; 600,000,000 shares authorized; 194,321,718 and 172,318,506 shares issued and outstanding at September 30, 2026 and December 31, 2025, respectively | |||||||||||||||||||
| Additional paid-in capital | |||||||||||||||||||
| Accumulated other comprehensive loss | |||||||||||||||||||
| Accumulated deficit | |||||||||||||||||||
| Total stockholders’ equity (deficit) | |||||||||||||||||||
| Total liabilities and stockholders’ equity (deficit) | |||||||||||||||||||
Loading...